Miami, Florida – The International Society for Stem Cell Application (ISSCA), a distinguished division of the Global Stem Cells Group (GSCG), is delighted to unveil its much-anticipated international symposium on Regenerative Medicine and Cellular Therapies. This groundbreaking event is set to take place in the vibrant city of Cancún, México, over three days, from June 14th to 16th, 2024, with one day dedicated to conferences and the subsequent two days featuring hands-on sessions.
A Global Gathering of Scientific Minds
The symposium aims to bring together leading scientists and medical professionals from around the world, providing an unparalleled platform to explore and discuss the latest advancements in regenerative medicine. With elite speakers, including renowned scientists and physicians with extensive experience in the field, attendees are expected to gain unique insights into the cutting-edge clinical applications of stem cell therapies.
Key Highlights of the Symposium
- Stay Ahead with the Latest Technologies:
Attendees will be at the forefront of breakthrough technologies in regenerative medicine. Learn about the most recent advancements that are reshaping the landscape of healthcare and discover how these technologies may elevate your practice and patient care.
- Explore Cutting-Edge Products and Equipment:
Gain firsthand insights into the latest products and equipment driving the field of stem cell therapy. From state-of-the-art medical devices to groundbreaking tools, discover innovations that may enhance your clinical practice and contribute to better patient outcomes.
- Delve into Tissue Engineering:
Tissue engineering is a frontier where science meets medical marvels. Attendees will have the opportunity to delve into the intricacies of tissue engineering, understanding how it is revolutionizing regenerative medicine and paving the way for transformative treatments.
- Comprehensive Understanding of Regenerative Medicine:
Broaden your understanding of regenerative medicine as a whole. From foundational principles to cutting-edge applications, the symposium provides a comprehensive overview, equipping attendees with the knowledge needed to excel in this rapidly evolving field.
- Network with Industry Leaders and Peers:
Connect with a diverse and dynamic community of professionals, including doctors, researchers, innovators, and decision-makers. Engage in meaningful conversations, forge collaborations, and build a network that extends beyond the symposium, providing ongoing support and insights.
- Acquire Practical Knowledge from Hands-On Training:
Beyond theoretical insights, the symposium offers invaluable hands-on training sessions led by ISSCA-certified instructors. Gain practical experience in the aesthetic and clinical applications of stem cell therapy, ensuring you leave with skills ready for immediate implementation.
- Navigate Regulatory:
Stay informed on the latest regulatory and ethical considerations in stem cell technology. Navigate the complexities of compliance while gaining insights into how to address challenges in a rapidly evolving regulatory landscape.
- Stay Informed on Marketing Trends:
Learn about modern technologies that can enhance your marketing efforts in the field of regenerative medicine. Stay ahead of the curve with insights into effective strategies to promote your practice and reach a wider audience.
In short, the ISSCA International Symposium is not just an event; it is an immersive experience that seeks to empower attendees with the knowledge, skills and connections needed to shape the future of regenerative medicine. Join us in Cancun, Mexico, and be a catalyst for positive change in the medical landscape.
For registration and additional information, please contact:
Email: info@stemcellsgroup.com
Phone: +1305 560 5337
About ISSCA:
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians who aspire to treat diseases and lessen human suffering through advances in science, technology, and the practice of regenerative medicine. ISSCA serves its members through advancements made in the specialty of regenerative medicine.
The mission of ISSCA is to establish itself as a global leader in regenerative medicine certification, education, research, and training.
ISSCA provides certification training in cities worldwide because it recognizes the importance of standards and certifications in regenerative medicine as a medical specialty. To help more people, both locally and globally, as the demand for more doctors interested in and comfortable with regenerative medicine surges. ISSCA’s mission is to advance quality and uniformity in regenerative medicine worldwide.
About Global Stem Cells Group:
The Global Stem Cell Group is a family of several companies focused on stem cell medicine and research. The company uses its network to bring leadership in regenerative medicine training, research, and patient applications.
GSCG’s mission is to allow physicians to present the benefits of stem cell medicine to patients worldwide. The company also partners with policymakers, educators, and regulators to promote regenerative medicine.
Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/
To learn more about Global Stem Cells Group, Inc.’s companies visit our website www.stemcellsgroup.com or call +1 305 560 5331
Safe Harbor Statement:
Statements in this news release may be “forward-looking statements”. Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions, or any other information relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates, and projections about our business based partly on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual outcomes and results may and are likely to differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release, and The Global Stem Cells Group undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release. This press release does not constitute a public offer of any securities for sale. Any securities offered privately will not be or have not been registered under the Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.
